Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Radioactive substances such as strontium-89 may relieve bone pain
associated with prostate cancer. It is not yet known whether chemotherapy is more effective
with or without strontium-89 in treating bone metastases.
PURPOSE: This randomized phase III trial is studying giving chemotherapy together with
strontium-89 to see how well it works compared to chemotherapy alone in treating patients
with prostate cancer that has spread to the bone.